Product Information
SKYRIZI 150 MG/ML SYRINGE is a brand product labeled by AbbVie Inc., priced at $22942.3716 per ML under NDC 00074105001. Its NADAC has been published 206 times since Jul 20, 2022.
Strength
150 mg/mL
Manufacturer
AbbVie Inc.NDC
00074105001
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
1/2/2026
Active Ingredients
RISANKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761105On Market Since
4/26/2021
Pharmacological Classes
Price Statistics
The NADAC for SKYRIZI 150 MG/ML SYRINGE has been published 206 times since Jul 20, 2022, and over the history we have for it it has risen 28.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22942.3716 per ML |
|---|---|
| All-time high | $22942.3716 (Jun 24, 2026) |
| All-time low | $17835.5520 (Jul 20, 2022) |
| 52-week high | $22942.3716 |
| 52-week low | $21502.8571 |
| Median price | $20346.3057 |
| Average price | $20395.6278 |
| Largest weekly change | +8.0% (Jan 11, 2023) |
| Weeks tracked | 206 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SKYRIZI 150 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for SKYRIZI 150 MG/ML SYRINGE, manufactured by AbbVie Inc., is $22942.3716 per ML (NDC 00074105001), effective Jun 24, 2026.
How has the price of SKYRIZI 150 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for SKYRIZI 150 MG/ML SYRINGE has risen 28.6%. It has been tracked across 206 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for SKYRIZI 150 MG/ML SYRINGE?
Since Jul 20, 2022, the NADAC for SKYRIZI 150 MG/ML SYRINGE has ranged from a low of $17835.5520 (Jul 20, 2022) to a high of $22942.3716 (Jun 24, 2026), with a median of $20346.3057 per ML.
Are there cheaper alternatives to SKYRIZI 150 MG/ML SYRINGE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SKYRIZI 150 MG/ML PEN, is $22710.1121 per ML — about 1% below SKYRIZI 150 MG/ML SYRINGE.
Who manufactures SKYRIZI 150 MG/ML SYRINGE?
SKYRIZI 150 MG/ML SYRINGE (NDC 00074105001) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification